nodes	percent_of_prediction	percent_of_DWPC	metapath
Frovatriptan—CYP1A2—type 2 diabetes mellitus	0.331	1	CbGaD
Frovatriptan—HTR1D—Bromocriptine—type 2 diabetes mellitus	0.119	0.285	CbGbCtD
Frovatriptan—HTR1B—Bromocriptine—type 2 diabetes mellitus	0.114	0.273	CbGbCtD
Frovatriptan—HTR1A—Bromocriptine—type 2 diabetes mellitus	0.0717	0.171	CbGbCtD
Frovatriptan—CYP1A2—Rosiglitazone—type 2 diabetes mellitus	0.0372	0.0888	CbGbCtD
Frovatriptan—CYP1A2—Irbesartan—type 2 diabetes mellitus	0.0293	0.0699	CbGbCtD
Frovatriptan—CYP1A2—Bromocriptine—type 2 diabetes mellitus	0.0277	0.0661	CbGbCtD
Frovatriptan—CYP1A2—Losartan—type 2 diabetes mellitus	0.0189	0.0451	CbGbCtD
Frovatriptan—Tremor—Irbesartan—type 2 diabetes mellitus	0.000135	0.000689	CcSEcCtD
Frovatriptan—Palpitations—Metformin—type 2 diabetes mellitus	0.000135	0.000689	CcSEcCtD
Frovatriptan—Insomnia—Gliclazide—type 2 diabetes mellitus	0.000134	0.000688	CcSEcCtD
Frovatriptan—Shock—Valsartan—type 2 diabetes mellitus	0.000134	0.000687	CcSEcCtD
Frovatriptan—Loss of consciousness—Metformin—type 2 diabetes mellitus	0.000134	0.000685	CcSEcCtD
Frovatriptan—Paraesthesia—Gliclazide—type 2 diabetes mellitus	0.000133	0.000683	CcSEcCtD
Frovatriptan—Ill-defined disorder—Irbesartan—type 2 diabetes mellitus	0.000133	0.000683	CcSEcCtD
Frovatriptan—Flatulence—Losartan—type 2 diabetes mellitus	0.000133	0.000682	CcSEcCtD
Frovatriptan—Tension—Losartan—type 2 diabetes mellitus	0.000133	0.000679	CcSEcCtD
Frovatriptan—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000133	0.000679	CcSEcCtD
Frovatriptan—Dysgeusia—Losartan—type 2 diabetes mellitus	0.000132	0.000678	CcSEcCtD
Frovatriptan—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.000132	0.000678	CcSEcCtD
Frovatriptan—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000132	0.000677	CcSEcCtD
Frovatriptan—Agitation—Irbesartan—type 2 diabetes mellitus	0.000132	0.000676	CcSEcCtD
Frovatriptan—Somnolence—Gliclazide—type 2 diabetes mellitus	0.000132	0.000676	CcSEcCtD
Frovatriptan—Nervousness—Losartan—type 2 diabetes mellitus	0.000131	0.000673	CcSEcCtD
Frovatriptan—Back pain—Losartan—type 2 diabetes mellitus	0.000131	0.00067	CcSEcCtD
Frovatriptan—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000131	0.00067	CcSEcCtD
Frovatriptan—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000131	0.000669	CcSEcCtD
Frovatriptan—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.00013	0.000667	CcSEcCtD
Frovatriptan—Anorexia—Valsartan—type 2 diabetes mellitus	0.00013	0.000666	CcSEcCtD
Frovatriptan—Muscle spasms—Losartan—type 2 diabetes mellitus	0.00013	0.000666	CcSEcCtD
Frovatriptan—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.00013	0.000665	CcSEcCtD
Frovatriptan—Chest pain—Metformin—type 2 diabetes mellitus	0.00013	0.000664	CcSEcCtD
Frovatriptan—Myalgia—Metformin—type 2 diabetes mellitus	0.00013	0.000664	CcSEcCtD
Frovatriptan—Malaise—Irbesartan—type 2 diabetes mellitus	0.00013	0.000664	CcSEcCtD
Frovatriptan—Vertigo—Irbesartan—type 2 diabetes mellitus	0.000129	0.000661	CcSEcCtD
Frovatriptan—Headache—Pioglitazone—type 2 diabetes mellitus	0.000129	0.000661	CcSEcCtD
Frovatriptan—Syncope—Irbesartan—type 2 diabetes mellitus	0.000129	0.00066	CcSEcCtD
Frovatriptan—Visual impairment—Ramipril—type 2 diabetes mellitus	0.000128	0.000657	CcSEcCtD
Frovatriptan—Discomfort—Metformin—type 2 diabetes mellitus	0.000128	0.000656	CcSEcCtD
Frovatriptan—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000128	0.000656	CcSEcCtD
Frovatriptan—Nausea—Glipizide—type 2 diabetes mellitus	0.000128	0.000654	CcSEcCtD
Frovatriptan—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000128	0.000653	CcSEcCtD
Frovatriptan—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000127	0.000651	CcSEcCtD
Frovatriptan—Pain—Gliclazide—type 2 diabetes mellitus	0.000127	0.00065	CcSEcCtD
Frovatriptan—Constipation—Gliclazide—type 2 diabetes mellitus	0.000127	0.00065	CcSEcCtD
Frovatriptan—Tremor—Losartan—type 2 diabetes mellitus	0.000127	0.000649	CcSEcCtD
Frovatriptan—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	0.000126	0.000647	CcSEcCtD
Frovatriptan—Headache—Glimepiride—type 2 diabetes mellitus	0.000126	0.000643	CcSEcCtD
Frovatriptan—Ill-defined disorder—Losartan—type 2 diabetes mellitus	0.000126	0.000642	CcSEcCtD
Frovatriptan—Headache—Sitagliptin—type 2 diabetes mellitus	0.000125	0.000641	CcSEcCtD
Frovatriptan—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.000124	0.000637	CcSEcCtD
Frovatriptan—Agitation—Losartan—type 2 diabetes mellitus	0.000124	0.000636	CcSEcCtD
Frovatriptan—Tinnitus—Ramipril—type 2 diabetes mellitus	0.000124	0.000636	CcSEcCtD
Frovatriptan—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000124	0.000634	CcSEcCtD
Frovatriptan—Flushing—Ramipril—type 2 diabetes mellitus	0.000124	0.000633	CcSEcCtD
Frovatriptan—Insomnia—Valsartan—type 2 diabetes mellitus	0.000123	0.000632	CcSEcCtD
Frovatriptan—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000123	0.000629	CcSEcCtD
Frovatriptan—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000123	0.000627	CcSEcCtD
Frovatriptan—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000122	0.000627	CcSEcCtD
Frovatriptan—Chest pain—Irbesartan—type 2 diabetes mellitus	0.000122	0.000626	CcSEcCtD
Frovatriptan—Arthralgia—Irbesartan—type 2 diabetes mellitus	0.000122	0.000626	CcSEcCtD
Frovatriptan—Myalgia—Irbesartan—type 2 diabetes mellitus	0.000122	0.000626	CcSEcCtD
Frovatriptan—Shock—Metformin—type 2 diabetes mellitus	0.000122	0.000626	CcSEcCtD
Frovatriptan—Insomnia—Orlistat—type 2 diabetes mellitus	0.000122	0.000624	CcSEcCtD
Frovatriptan—Malaise—Losartan—type 2 diabetes mellitus	0.000122	0.000624	CcSEcCtD
Frovatriptan—Anxiety—Irbesartan—type 2 diabetes mellitus	0.000122	0.000624	CcSEcCtD
Frovatriptan—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000122	0.000624	CcSEcCtD
Frovatriptan—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000122	0.000623	CcSEcCtD
Frovatriptan—Vertigo—Losartan—type 2 diabetes mellitus	0.000122	0.000622	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000121	0.000622	CcSEcCtD
Frovatriptan—Somnolence—Valsartan—type 2 diabetes mellitus	0.000121	0.000621	CcSEcCtD
Frovatriptan—Syncope—Losartan—type 2 diabetes mellitus	0.000121	0.000621	CcSEcCtD
Frovatriptan—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000121	0.00062	CcSEcCtD
Frovatriptan—Discomfort—Irbesartan—type 2 diabetes mellitus	0.000121	0.000619	CcSEcCtD
Frovatriptan—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.00012	0.000615	CcSEcCtD
Frovatriptan—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.00012	0.000615	CcSEcCtD
Frovatriptan—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.00012	0.000613	CcSEcCtD
Frovatriptan—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.00012	0.000613	CcSEcCtD
Frovatriptan—Palpitations—Losartan—type 2 diabetes mellitus	0.00012	0.000612	CcSEcCtD
Frovatriptan—Nausea—Glimepiride—type 2 diabetes mellitus	0.000119	0.00061	CcSEcCtD
Frovatriptan—Arrhythmia—Ramipril—type 2 diabetes mellitus	0.000119	0.000609	CcSEcCtD
Frovatriptan—Loss of consciousness—Losartan—type 2 diabetes mellitus	0.000119	0.000609	CcSEcCtD
Frovatriptan—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000119	0.000608	CcSEcCtD
Frovatriptan—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000119	0.000608	CcSEcCtD
Frovatriptan—Asthenia—Glyburide—type 2 diabetes mellitus	0.000119	0.000608	CcSEcCtD
Frovatriptan—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000119	0.000607	CcSEcCtD
Frovatriptan—Anorexia—Metformin—type 2 diabetes mellitus	0.000118	0.000607	CcSEcCtD
Frovatriptan—Fatigue—Valsartan—type 2 diabetes mellitus	0.000118	0.000602	CcSEcCtD
Frovatriptan—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000117	0.000601	CcSEcCtD
Frovatriptan—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000117	0.000601	CcSEcCtD
Frovatriptan—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.000117	0.000601	CcSEcCtD
Frovatriptan—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000117	0.0006	CcSEcCtD
Frovatriptan—Pruritus—Glyburide—type 2 diabetes mellitus	0.000117	0.000599	CcSEcCtD
Frovatriptan—Mental disorder—Ramipril—type 2 diabetes mellitus	0.000117	0.000598	CcSEcCtD
Frovatriptan—Constipation—Valsartan—type 2 diabetes mellitus	0.000117	0.000598	CcSEcCtD
Frovatriptan—Fatigue—Orlistat—type 2 diabetes mellitus	0.000116	0.000595	CcSEcCtD
Frovatriptan—Malnutrition—Ramipril—type 2 diabetes mellitus	0.000116	0.000594	CcSEcCtD
Frovatriptan—Shock—Irbesartan—type 2 diabetes mellitus	0.000115	0.000591	CcSEcCtD
Frovatriptan—Pain—Orlistat—type 2 diabetes mellitus	0.000115	0.00059	CcSEcCtD
Frovatriptan—Myalgia—Losartan—type 2 diabetes mellitus	0.000115	0.00059	CcSEcCtD
Frovatriptan—Arthralgia—Losartan—type 2 diabetes mellitus	0.000115	0.00059	CcSEcCtD
Frovatriptan—Chest pain—Losartan—type 2 diabetes mellitus	0.000115	0.00059	CcSEcCtD
Frovatriptan—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000115	0.000589	CcSEcCtD
Frovatriptan—Anxiety—Losartan—type 2 diabetes mellitus	0.000115	0.000587	CcSEcCtD
Frovatriptan—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.000114	0.000586	CcSEcCtD
Frovatriptan—Tension—Ramipril—type 2 diabetes mellitus	0.000114	0.000583	CcSEcCtD
Frovatriptan—Discomfort—Losartan—type 2 diabetes mellitus	0.000114	0.000582	CcSEcCtD
Frovatriptan—Dysgeusia—Ramipril—type 2 diabetes mellitus	0.000114	0.000581	CcSEcCtD
Frovatriptan—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.000113	0.000581	CcSEcCtD
Frovatriptan—Headache—Bromocriptine—type 2 diabetes mellitus	0.000113	0.00058	CcSEcCtD
Frovatriptan—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000113	0.00058	CcSEcCtD
Frovatriptan—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000113	0.00058	CcSEcCtD
Frovatriptan—Nervousness—Ramipril—type 2 diabetes mellitus	0.000113	0.000577	CcSEcCtD
Frovatriptan—Dry mouth—Losartan—type 2 diabetes mellitus	0.000113	0.000577	CcSEcCtD
Frovatriptan—Anorexia—Irbesartan—type 2 diabetes mellitus	0.000112	0.000572	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000112	0.000571	CcSEcCtD
Frovatriptan—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000112	0.000571	CcSEcCtD
Frovatriptan—Muscle spasms—Ramipril—type 2 diabetes mellitus	0.000112	0.000571	CcSEcCtD
Frovatriptan—Confusional state—Losartan—type 2 diabetes mellitus	0.000111	0.00057	CcSEcCtD
Frovatriptan—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000111	0.000569	CcSEcCtD
Frovatriptan—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000111	0.000567	CcSEcCtD
Frovatriptan—Somnolence—Metformin—type 2 diabetes mellitus	0.000111	0.000566	CcSEcCtD
Frovatriptan—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.00011	0.000565	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.00011	0.000565	CcSEcCtD
Frovatriptan—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000109	0.00056	CcSEcCtD
Frovatriptan—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000109	0.00056	CcSEcCtD
Frovatriptan—Tremor—Ramipril—type 2 diabetes mellitus	0.000109	0.000556	CcSEcCtD
Frovatriptan—Shock—Losartan—type 2 diabetes mellitus	0.000109	0.000556	CcSEcCtD
Frovatriptan—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000108	0.000553	CcSEcCtD
Frovatriptan—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000108	0.000552	CcSEcCtD
Frovatriptan—Tachycardia—Losartan—type 2 diabetes mellitus	0.000108	0.000552	CcSEcCtD
Frovatriptan—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	0.000108	0.000551	CcSEcCtD
Frovatriptan—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000108	0.00055	CcSEcCtD
Frovatriptan—Fatigue—Metformin—type 2 diabetes mellitus	0.000107	0.000549	CcSEcCtD
Frovatriptan—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.000107	0.000547	CcSEcCtD
Frovatriptan—Hyperhidrosis—Losartan—type 2 diabetes mellitus	0.000107	0.000546	CcSEcCtD
Frovatriptan—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000107	0.000546	CcSEcCtD
Frovatriptan—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000107	0.000546	CcSEcCtD
Frovatriptan—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000107	0.000546	CcSEcCtD
Frovatriptan—Agitation—Ramipril—type 2 diabetes mellitus	0.000107	0.000546	CcSEcCtD
Frovatriptan—Constipation—Metformin—type 2 diabetes mellitus	0.000106	0.000544	CcSEcCtD
Frovatriptan—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.000105	0.000539	CcSEcCtD
Frovatriptan—Anorexia—Losartan—type 2 diabetes mellitus	0.000105	0.000539	CcSEcCtD
Frovatriptan—Vomiting—Glyburide—type 2 diabetes mellitus	0.000105	0.000539	CcSEcCtD
Frovatriptan—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000105	0.000538	CcSEcCtD
Frovatriptan—Malaise—Ramipril—type 2 diabetes mellitus	0.000105	0.000535	CcSEcCtD
Frovatriptan—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000105	0.000535	CcSEcCtD
Frovatriptan—Somnolence—Irbesartan—type 2 diabetes mellitus	0.000104	0.000534	CcSEcCtD
Frovatriptan—Vertigo—Ramipril—type 2 diabetes mellitus	0.000104	0.000533	CcSEcCtD
Frovatriptan—Syncope—Ramipril—type 2 diabetes mellitus	0.000104	0.000532	CcSEcCtD
Frovatriptan—Headache—Glyburide—type 2 diabetes mellitus	0.000104	0.000531	CcSEcCtD
Frovatriptan—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000103	0.000529	CcSEcCtD
Frovatriptan—Palpitations—Ramipril—type 2 diabetes mellitus	0.000102	0.000525	CcSEcCtD
Frovatriptan—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.000102	0.000524	CcSEcCtD
Frovatriptan—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000102	0.000522	CcSEcCtD
Frovatriptan—Loss of consciousness—Ramipril—type 2 diabetes mellitus	0.000102	0.000522	CcSEcCtD
Frovatriptan—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000102	0.00052	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000102	0.00052	CcSEcCtD
Frovatriptan—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000101	0.000518	CcSEcCtD
Frovatriptan—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.000101	0.000515	CcSEcCtD
Frovatriptan—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000101	0.000515	CcSEcCtD
Frovatriptan—Convulsion—Ramipril—type 2 diabetes mellitus	0.0001	0.000514	CcSEcCtD
Frovatriptan—Pain—Irbesartan—type 2 diabetes mellitus	0.0001	0.000514	CcSEcCtD
Frovatriptan—Constipation—Irbesartan—type 2 diabetes mellitus	0.0001	0.000514	CcSEcCtD
Frovatriptan—Insomnia—Losartan—type 2 diabetes mellitus	9.99e-05	0.000511	CcSEcCtD
Frovatriptan—Hypersensitivity—Orlistat—type 2 diabetes mellitus	9.94e-05	0.000509	CcSEcCtD
Frovatriptan—Paraesthesia—Losartan—type 2 diabetes mellitus	9.91e-05	0.000507	CcSEcCtD
Frovatriptan—Myalgia—Ramipril—type 2 diabetes mellitus	9.87e-05	0.000505	CcSEcCtD
Frovatriptan—Chest pain—Ramipril—type 2 diabetes mellitus	9.87e-05	0.000505	CcSEcCtD
Frovatriptan—Arthralgia—Ramipril—type 2 diabetes mellitus	9.87e-05	0.000505	CcSEcCtD
Frovatriptan—Dyspnoea—Losartan—type 2 diabetes mellitus	9.84e-05	0.000504	CcSEcCtD
Frovatriptan—Anxiety—Ramipril—type 2 diabetes mellitus	9.84e-05	0.000504	CcSEcCtD
Frovatriptan—Nausea—Glyburide—type 2 diabetes mellitus	9.83e-05	0.000503	CcSEcCtD
Frovatriptan—Abdominal pain—Metformin—type 2 diabetes mellitus	9.83e-05	0.000503	CcSEcCtD
Frovatriptan—Dizziness—Gliclazide—type 2 diabetes mellitus	9.82e-05	0.000503	CcSEcCtD
Frovatriptan—Somnolence—Losartan—type 2 diabetes mellitus	9.81e-05	0.000502	CcSEcCtD
Frovatriptan—Asthenia—Valsartan—type 2 diabetes mellitus	9.79e-05	0.000501	CcSEcCtD
Frovatriptan—Discomfort—Ramipril—type 2 diabetes mellitus	9.76e-05	0.000499	CcSEcCtD
Frovatriptan—Dyspepsia—Losartan—type 2 diabetes mellitus	9.72e-05	0.000497	CcSEcCtD
Frovatriptan—Asthenia—Orlistat—type 2 diabetes mellitus	9.68e-05	0.000495	CcSEcCtD
Frovatriptan—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	9.67e-05	0.000495	CcSEcCtD
Frovatriptan—Pruritus—Valsartan—type 2 diabetes mellitus	9.66e-05	0.000494	CcSEcCtD
Frovatriptan—Dry mouth—Ramipril—type 2 diabetes mellitus	9.66e-05	0.000494	CcSEcCtD
Frovatriptan—Decreased appetite—Losartan—type 2 diabetes mellitus	9.6e-05	0.000491	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	9.59e-05	0.000491	CcSEcCtD
Frovatriptan—Confusional state—Ramipril—type 2 diabetes mellitus	9.54e-05	0.000489	CcSEcCtD
Frovatriptan—Pruritus—Orlistat—type 2 diabetes mellitus	9.54e-05	0.000489	CcSEcCtD
Frovatriptan—Fatigue—Losartan—type 2 diabetes mellitus	9.52e-05	0.000487	CcSEcCtD
Frovatriptan—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	9.47e-05	0.000485	CcSEcCtD
Frovatriptan—Vomiting—Gliclazide—type 2 diabetes mellitus	9.45e-05	0.000484	CcSEcCtD
Frovatriptan—Pain—Losartan—type 2 diabetes mellitus	9.44e-05	0.000483	CcSEcCtD
Frovatriptan—Constipation—Losartan—type 2 diabetes mellitus	9.44e-05	0.000483	CcSEcCtD
Frovatriptan—Diarrhoea—Valsartan—type 2 diabetes mellitus	9.34e-05	0.000478	CcSEcCtD
Frovatriptan—Shock—Ramipril—type 2 diabetes mellitus	9.31e-05	0.000477	CcSEcCtD
Frovatriptan—Headache—Gliclazide—type 2 diabetes mellitus	9.31e-05	0.000476	CcSEcCtD
Frovatriptan—Abdominal pain—Irbesartan—type 2 diabetes mellitus	9.27e-05	0.000475	CcSEcCtD
Frovatriptan—Body temperature increased—Irbesartan—type 2 diabetes mellitus	9.27e-05	0.000475	CcSEcCtD
Frovatriptan—Tachycardia—Ramipril—type 2 diabetes mellitus	9.24e-05	0.000473	CcSEcCtD
Frovatriptan—Diarrhoea—Orlistat—type 2 diabetes mellitus	9.23e-05	0.000472	CcSEcCtD
Frovatriptan—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	9.15e-05	0.000468	CcSEcCtD
Frovatriptan—Feeling abnormal—Losartan—type 2 diabetes mellitus	9.1e-05	0.000466	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	9.03e-05	0.000462	CcSEcCtD
Frovatriptan—Dizziness—Valsartan—type 2 diabetes mellitus	9.03e-05	0.000462	CcSEcCtD
Frovatriptan—Anorexia—Ramipril—type 2 diabetes mellitus	9.02e-05	0.000462	CcSEcCtD
Frovatriptan—Dizziness—Orlistat—type 2 diabetes mellitus	8.92e-05	0.000457	CcSEcCtD
Frovatriptan—Asthenia—Metformin—type 2 diabetes mellitus	8.92e-05	0.000457	CcSEcCtD
Frovatriptan—Nausea—Gliclazide—type 2 diabetes mellitus	8.83e-05	0.000452	CcSEcCtD
Frovatriptan—Pruritus—Metformin—type 2 diabetes mellitus	8.79e-05	0.00045	CcSEcCtD
Frovatriptan—Abdominal pain—Losartan—type 2 diabetes mellitus	8.73e-05	0.000447	CcSEcCtD
Frovatriptan—Body temperature increased—Losartan—type 2 diabetes mellitus	8.73e-05	0.000447	CcSEcCtD
Frovatriptan—Vomiting—Valsartan—type 2 diabetes mellitus	8.68e-05	0.000444	CcSEcCtD
Frovatriptan—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	8.64e-05	0.000442	CcSEcCtD
Frovatriptan—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	8.62e-05	0.000441	CcSEcCtD
Frovatriptan—Vomiting—Orlistat—type 2 diabetes mellitus	8.58e-05	0.000439	CcSEcCtD
Frovatriptan—Insomnia—Ramipril—type 2 diabetes mellitus	8.56e-05	0.000438	CcSEcCtD
Frovatriptan—Headache—Valsartan—type 2 diabetes mellitus	8.55e-05	0.000438	CcSEcCtD
Frovatriptan—Diarrhoea—Metformin—type 2 diabetes mellitus	8.51e-05	0.000435	CcSEcCtD
Frovatriptan—Paraesthesia—Ramipril—type 2 diabetes mellitus	8.5e-05	0.000435	CcSEcCtD
Frovatriptan—Headache—Orlistat—type 2 diabetes mellitus	8.45e-05	0.000433	CcSEcCtD
Frovatriptan—Dyspnoea—Ramipril—type 2 diabetes mellitus	8.44e-05	0.000432	CcSEcCtD
Frovatriptan—Asthenia—Irbesartan—type 2 diabetes mellitus	8.42e-05	0.000431	CcSEcCtD
Frovatriptan—Somnolence—Ramipril—type 2 diabetes mellitus	8.42e-05	0.000431	CcSEcCtD
Frovatriptan—Dyspepsia—Ramipril—type 2 diabetes mellitus	8.33e-05	0.000427	CcSEcCtD
Frovatriptan—Pruritus—Irbesartan—type 2 diabetes mellitus	8.3e-05	0.000425	CcSEcCtD
Frovatriptan—Decreased appetite—Ramipril—type 2 diabetes mellitus	8.23e-05	0.000421	CcSEcCtD
Frovatriptan—Dizziness—Metformin—type 2 diabetes mellitus	8.22e-05	0.000421	CcSEcCtD
Frovatriptan—Fatigue—Ramipril—type 2 diabetes mellitus	8.16e-05	0.000418	CcSEcCtD
Frovatriptan—Hypersensitivity—Losartan—type 2 diabetes mellitus	8.13e-05	0.000416	CcSEcCtD
Frovatriptan—Nausea—Valsartan—type 2 diabetes mellitus	8.11e-05	0.000415	CcSEcCtD
Frovatriptan—Constipation—Ramipril—type 2 diabetes mellitus	8.09e-05	0.000414	CcSEcCtD
Frovatriptan—Diarrhoea—Irbesartan—type 2 diabetes mellitus	8.03e-05	0.000411	CcSEcCtD
Frovatriptan—Nausea—Orlistat—type 2 diabetes mellitus	8.01e-05	0.00041	CcSEcCtD
Frovatriptan—Asthenia—Losartan—type 2 diabetes mellitus	7.92e-05	0.000405	CcSEcCtD
Frovatriptan—Vomiting—Metformin—type 2 diabetes mellitus	7.9e-05	0.000405	CcSEcCtD
Frovatriptan—Pruritus—Losartan—type 2 diabetes mellitus	7.81e-05	0.0004	CcSEcCtD
Frovatriptan—Feeling abnormal—Ramipril—type 2 diabetes mellitus	7.8e-05	0.000399	CcSEcCtD
Frovatriptan—Headache—Metformin—type 2 diabetes mellitus	7.79e-05	0.000399	CcSEcCtD
Frovatriptan—Dizziness—Irbesartan—type 2 diabetes mellitus	7.76e-05	0.000397	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	7.74e-05	0.000396	CcSEcCtD
Frovatriptan—Diarrhoea—Losartan—type 2 diabetes mellitus	7.55e-05	0.000387	CcSEcCtD
Frovatriptan—Abdominal pain—Ramipril—type 2 diabetes mellitus	7.48e-05	0.000383	CcSEcCtD
Frovatriptan—Body temperature increased—Ramipril—type 2 diabetes mellitus	7.48e-05	0.000383	CcSEcCtD
Frovatriptan—Vomiting—Irbesartan—type 2 diabetes mellitus	7.46e-05	0.000382	CcSEcCtD
Frovatriptan—Nausea—Metformin—type 2 diabetes mellitus	7.38e-05	0.000378	CcSEcCtD
Frovatriptan—Headache—Irbesartan—type 2 diabetes mellitus	7.35e-05	0.000376	CcSEcCtD
Frovatriptan—Dizziness—Losartan—type 2 diabetes mellitus	7.3e-05	0.000374	CcSEcCtD
Frovatriptan—Vomiting—Losartan—type 2 diabetes mellitus	7.02e-05	0.000359	CcSEcCtD
Frovatriptan—Hypersensitivity—Ramipril—type 2 diabetes mellitus	6.97e-05	0.000357	CcSEcCtD
Frovatriptan—Nausea—Irbesartan—type 2 diabetes mellitus	6.97e-05	0.000357	CcSEcCtD
Frovatriptan—Headache—Losartan—type 2 diabetes mellitus	6.92e-05	0.000354	CcSEcCtD
Frovatriptan—Asthenia—Ramipril—type 2 diabetes mellitus	6.79e-05	0.000348	CcSEcCtD
Frovatriptan—Pruritus—Ramipril—type 2 diabetes mellitus	6.7e-05	0.000343	CcSEcCtD
Frovatriptan—Nausea—Losartan—type 2 diabetes mellitus	6.56e-05	0.000336	CcSEcCtD
Frovatriptan—Diarrhoea—Ramipril—type 2 diabetes mellitus	6.48e-05	0.000332	CcSEcCtD
Frovatriptan—Dizziness—Ramipril—type 2 diabetes mellitus	6.26e-05	0.00032	CcSEcCtD
Frovatriptan—Vomiting—Ramipril—type 2 diabetes mellitus	6.02e-05	0.000308	CcSEcCtD
Frovatriptan—Headache—Ramipril—type 2 diabetes mellitus	5.93e-05	0.000304	CcSEcCtD
Frovatriptan—Nausea—Ramipril—type 2 diabetes mellitus	5.62e-05	0.000288	CcSEcCtD
Frovatriptan—CYP1A2—Metabolism—GCGR—type 2 diabetes mellitus	1.63e-05	0.000294	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—CCL2—type 2 diabetes mellitus	1.62e-05	0.000292	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—AGT—type 2 diabetes mellitus	1.61e-05	0.000291	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—TRPC6—type 2 diabetes mellitus	1.61e-05	0.00029	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	1.61e-05	0.00029	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—AGTR2—type 2 diabetes mellitus	1.6e-05	0.000289	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—AKT2—type 2 diabetes mellitus	1.59e-05	0.000287	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	1.59e-05	0.000287	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—CCL2—type 2 diabetes mellitus	1.58e-05	0.000286	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—CCR5—type 2 diabetes mellitus	1.58e-05	0.000285	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—AKT2—type 2 diabetes mellitus	1.56e-05	0.000281	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	1.55e-05	0.000281	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—C3—type 2 diabetes mellitus	1.54e-05	0.000278	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—OXCT1—type 2 diabetes mellitus	1.54e-05	0.000277	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—CYTB—type 2 diabetes mellitus	1.54e-05	0.000277	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—EDNRB—type 2 diabetes mellitus	1.53e-05	0.000277	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	1.5e-05	0.000271	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—SRD5A1—type 2 diabetes mellitus	1.5e-05	0.00027	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	1.49e-05	0.000269	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—GNB3—type 2 diabetes mellitus	1.49e-05	0.000269	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—PSMD6—type 2 diabetes mellitus	1.49e-05	0.000268	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—HTR2C—type 2 diabetes mellitus	1.49e-05	0.000268	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	1.47e-05	0.000266	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—AVP—type 2 diabetes mellitus	1.47e-05	0.000265	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—MMP3—type 2 diabetes mellitus	1.47e-05	0.000265	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—AGT—type 2 diabetes mellitus	1.46e-05	0.000264	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—IGF2—type 2 diabetes mellitus	1.46e-05	0.000264	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—GNB3—type 2 diabetes mellitus	1.46e-05	0.000263	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	1.46e-05	0.000263	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—EDNRA—type 2 diabetes mellitus	1.45e-05	0.000261	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	1.44e-05	0.00026	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—CALM1—type 2 diabetes mellitus	1.44e-05	0.00026	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CYBA—type 2 diabetes mellitus	1.44e-05	0.00026	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—AVP—type 2 diabetes mellitus	1.44e-05	0.00026	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—MMP3—type 2 diabetes mellitus	1.44e-05	0.00026	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—IGF2—type 2 diabetes mellitus	1.43e-05	0.000259	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—STAR—type 2 diabetes mellitus	1.43e-05	0.000258	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—ACACA—type 2 diabetes mellitus	1.43e-05	0.000258	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—HSD17B3—type 2 diabetes mellitus	1.43e-05	0.000258	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	1.43e-05	0.000258	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—APOB—type 2 diabetes mellitus	1.42e-05	0.000256	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	1.42e-05	0.000256	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—IGF1R—type 2 diabetes mellitus	1.41e-05	0.000255	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	1.41e-05	0.000255	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—PLAT—type 2 diabetes mellitus	1.41e-05	0.000254	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—GHRL—type 2 diabetes mellitus	1.41e-05	0.000254	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—EDN1—type 2 diabetes mellitus	1.4e-05	0.000252	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CALCA—type 2 diabetes mellitus	1.39e-05	0.000251	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—APOB—type 2 diabetes mellitus	1.39e-05	0.000251	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—IGF1R—type 2 diabetes mellitus	1.38e-05	0.00025	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—ABCC8—type 2 diabetes mellitus	1.37e-05	0.000247	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—CBS—type 2 diabetes mellitus	1.37e-05	0.000247	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—EDN1—type 2 diabetes mellitus	1.37e-05	0.000247	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—LPL—type 2 diabetes mellitus	1.36e-05	0.000245	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	1.35e-05	0.000244	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—LPL—type 2 diabetes mellitus	1.33e-05	0.00024	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—ADCY5—type 2 diabetes mellitus	1.33e-05	0.00024	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—SLC5A2—type 2 diabetes mellitus	1.32e-05	0.000238	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—COX2—type 2 diabetes mellitus	1.32e-05	0.000238	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	1.31e-05	0.000237	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	1.3e-05	0.000236	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—ADCY5—type 2 diabetes mellitus	1.3e-05	0.000235	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—NCOA6—type 2 diabetes mellitus	1.29e-05	0.000234	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	1.29e-05	0.000234	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—PTPN1—type 2 diabetes mellitus	1.29e-05	0.000233	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—GCG—type 2 diabetes mellitus	1.29e-05	0.000233	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—HSD11B1—type 2 diabetes mellitus	1.27e-05	0.00023	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—UCP2—type 2 diabetes mellitus	1.27e-05	0.00023	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—UCP3—type 2 diabetes mellitus	1.27e-05	0.00023	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	1.27e-05	0.00023	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	1.27e-05	0.000229	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	1.26e-05	0.000228	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—CCR5—type 2 diabetes mellitus	1.25e-05	0.000226	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	1.25e-05	0.000225	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	1.23e-05	0.000223	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—CCR5—type 2 diabetes mellitus	1.22e-05	0.000221	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—C3—type 2 diabetes mellitus	1.22e-05	0.00022	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—CCL2—type 2 diabetes mellitus	1.21e-05	0.000218	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—PCK1—type 2 diabetes mellitus	1.2e-05	0.000216	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—C3—type 2 diabetes mellitus	1.2e-05	0.000216	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—AKT2—type 2 diabetes mellitus	1.19e-05	0.000214	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	1.18e-05	0.000214	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	1.18e-05	0.000213	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—HIF1A—type 2 diabetes mellitus	1.16e-05	0.00021	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—IRS2—type 2 diabetes mellitus	1.16e-05	0.00021	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—AGT—type 2 diabetes mellitus	1.16e-05	0.000209	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	1.15e-05	0.000208	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—CALM1—type 2 diabetes mellitus	1.14e-05	0.000206	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—HIF1A—type 2 diabetes mellitus	1.14e-05	0.000206	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—IRS2—type 2 diabetes mellitus	1.14e-05	0.000205	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—APOE—type 2 diabetes mellitus	1.14e-05	0.000205	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—LEP—type 2 diabetes mellitus	1.14e-05	0.000205	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—AGT—type 2 diabetes mellitus	1.14e-05	0.000205	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—APOA1—type 2 diabetes mellitus	1.12e-05	0.000203	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	1.12e-05	0.000202	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—HK1—type 2 diabetes mellitus	1.12e-05	0.000202	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	1.12e-05	0.000202	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—CALM1—type 2 diabetes mellitus	1.12e-05	0.000202	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—LEP—type 2 diabetes mellitus	1.11e-05	0.000201	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—APOE—type 2 diabetes mellitus	1.11e-05	0.000201	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—GNB3—type 2 diabetes mellitus	1.11e-05	0.000201	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—APOA1—type 2 diabetes mellitus	1.1e-05	0.000199	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—AVP—type 2 diabetes mellitus	1.1e-05	0.000198	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—MMP3—type 2 diabetes mellitus	1.1e-05	0.000198	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—IGF2—type 2 diabetes mellitus	1.09e-05	0.000197	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	1.09e-05	0.000196	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—LPA—type 2 diabetes mellitus	1.08e-05	0.000195	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—GCKR—type 2 diabetes mellitus	1.08e-05	0.000195	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—KCNJ11—type 2 diabetes mellitus	1.08e-05	0.000195	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—HSD3B2—type 2 diabetes mellitus	1.08e-05	0.000195	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	1.08e-05	0.000194	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—PRKCB—type 2 diabetes mellitus	1.07e-05	0.000194	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—APOB—type 2 diabetes mellitus	1.06e-05	0.000191	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—IGF1R—type 2 diabetes mellitus	1.05e-05	0.00019	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—PRKCB—type 2 diabetes mellitus	1.05e-05	0.00019	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—EDN1—type 2 diabetes mellitus	1.04e-05	0.000188	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	1.04e-05	0.000188	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—ALDOB—type 2 diabetes mellitus	1.04e-05	0.000187	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.01e-05	0.000183	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—LPL—type 2 diabetes mellitus	1.01e-05	0.000183	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	1.01e-05	0.000182	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—IRS1—type 2 diabetes mellitus	9.93e-06	0.000179	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—ADCY5—type 2 diabetes mellitus	9.9e-06	0.000179	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	9.88e-06	0.000178	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	9.76e-06	0.000176	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—INS—type 2 diabetes mellitus	9.71e-06	0.000175	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—GLP1R—type 2 diabetes mellitus	9.65e-06	0.000174	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—CCL2—type 2 diabetes mellitus	9.55e-06	0.000173	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—INS—type 2 diabetes mellitus	9.51e-06	0.000172	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	9.49e-06	0.000171	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—IGF1—type 2 diabetes mellitus	9.39e-06	0.00017	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—AKT2—type 2 diabetes mellitus	9.39e-06	0.000169	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—CCL2—type 2 diabetes mellitus	9.35e-06	0.000169	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—EGFR—type 2 diabetes mellitus	9.35e-06	0.000169	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CCR5—type 2 diabetes mellitus	9.32e-06	0.000168	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—IGF1—type 2 diabetes mellitus	9.2e-06	0.000166	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—AKT2—type 2 diabetes mellitus	9.19e-06	0.000166	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—EGFR—type 2 diabetes mellitus	9.15e-06	0.000165	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—C3—type 2 diabetes mellitus	9.11e-06	0.000164	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—SLC2A2—type 2 diabetes mellitus	9.01e-06	0.000163	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	8.92e-06	0.000161	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—CPT1A—type 2 diabetes mellitus	8.82e-06	0.000159	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—MTR—type 2 diabetes mellitus	8.82e-06	0.000159	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	8.73e-06	0.000158	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—HIF1A—type 2 diabetes mellitus	8.68e-06	0.000157	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—IRS2—type 2 diabetes mellitus	8.66e-06	0.000156	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—NAMPT—type 2 diabetes mellitus	8.65e-06	0.000156	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—AGT—type 2 diabetes mellitus	8.65e-06	0.000156	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	8.6e-06	0.000155	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—LIPC—type 2 diabetes mellitus	8.6e-06	0.000155	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—HBA1—type 2 diabetes mellitus	8.6e-06	0.000155	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—GCK—type 2 diabetes mellitus	8.6e-06	0.000155	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—CYP11A1—type 2 diabetes mellitus	8.55e-06	0.000154	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	8.51e-06	0.000154	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—NOS3—type 2 diabetes mellitus	8.51e-06	0.000154	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CALM1—type 2 diabetes mellitus	8.51e-06	0.000154	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—APOE—type 2 diabetes mellitus	8.48e-06	0.000153	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—LEP—type 2 diabetes mellitus	8.48e-06	0.000153	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—SLC9A1—type 2 diabetes mellitus	8.39e-06	0.000152	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—APOA1—type 2 diabetes mellitus	8.38e-06	0.000151	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—NOS3—type 2 diabetes mellitus	8.34e-06	0.000151	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	8.34e-06	0.000151	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—CETP—type 2 diabetes mellitus	8.3e-06	0.00015	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—RELA—type 2 diabetes mellitus	8.01e-06	0.000145	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—PRKCB—type 2 diabetes mellitus	7.99e-06	0.000144	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—RELA—type 2 diabetes mellitus	7.85e-06	0.000142	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	7.74e-06	0.00014	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—SREBF1—type 2 diabetes mellitus	7.71e-06	0.000139	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—PSMD6—type 2 diabetes mellitus	7.71e-06	0.000139	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—SNAP25—type 2 diabetes mellitus	7.71e-06	0.000139	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—CTGF—type 2 diabetes mellitus	7.57e-06	0.000137	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—IRS1—type 2 diabetes mellitus	7.56e-06	0.000137	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—HMGCR—type 2 diabetes mellitus	7.5e-06	0.000135	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	7.4e-06	0.000134	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—ADRA2A—type 2 diabetes mellitus	7.34e-06	0.000133	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	7.3e-06	0.000132	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—INS—type 2 diabetes mellitus	7.24e-06	0.000131	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—CASP3—type 2 diabetes mellitus	7.23e-06	0.000131	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—IL6—type 2 diabetes mellitus	7.18e-06	0.00013	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	7.14e-06	0.000129	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CCL2—type 2 diabetes mellitus	7.13e-06	0.000129	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—CASP3—type 2 diabetes mellitus	7.08e-06	0.000128	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—CYP2E1—type 2 diabetes mellitus	7.05e-06	0.000127	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—IL6—type 2 diabetes mellitus	7.03e-06	0.000127	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—IGF1—type 2 diabetes mellitus	7.01e-06	0.000127	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—AKT2—type 2 diabetes mellitus	7e-06	0.000126	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—SLC2A1—type 2 diabetes mellitus	6.98e-06	0.000126	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	6.97e-06	0.000126	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—MMP9—type 2 diabetes mellitus	6.83e-06	0.000123	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—CYP3A4—type 2 diabetes mellitus	6.8e-06	0.000123	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	6.77e-06	0.000122	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—NFKB1—type 2 diabetes mellitus	6.76e-06	0.000122	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—MMP9—type 2 diabetes mellitus	6.69e-06	0.000121	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—SLC2A4—type 2 diabetes mellitus	6.69e-06	0.000121	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—GCG—type 2 diabetes mellitus	6.69e-06	0.000121	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	6.65e-06	0.00012	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—AKT1—type 2 diabetes mellitus	6.63e-06	0.00012	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—NFKB1—type 2 diabetes mellitus	6.62e-06	0.00012	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—AKT1—type 2 diabetes mellitus	6.49e-06	0.000117	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	6.35e-06	0.000115	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—NOS3—type 2 diabetes mellitus	6.35e-06	0.000115	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—SRC—type 2 diabetes mellitus	6.3e-06	0.000114	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—SRC—type 2 diabetes mellitus	6.17e-06	0.000111	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—VEGFA—type 2 diabetes mellitus	6.13e-06	0.000111	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—VEGFA—type 2 diabetes mellitus	6.01e-06	0.000108	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—RELA—type 2 diabetes mellitus	5.98e-06	0.000108	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—PPARGC1A—type 2 diabetes mellitus	5.76e-06	0.000104	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—GNB3—type 2 diabetes mellitus	5.76e-06	0.000104	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—HMOX1—type 2 diabetes mellitus	5.74e-06	0.000104	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—CAT—type 2 diabetes mellitus	5.66e-06	0.000102	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—TGFB1—type 2 diabetes mellitus	5.63e-06	0.000102	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—EGFR—type 2 diabetes mellitus	5.52e-06	9.97e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—TGFB1—type 2 diabetes mellitus	5.51e-06	9.96e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—APOB—type 2 diabetes mellitus	5.5e-06	9.92e-05	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	5.44e-06	9.83e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—EGFR—type 2 diabetes mellitus	5.41e-06	9.76e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CASP3—type 2 diabetes mellitus	5.39e-06	9.74e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—IL6—type 2 diabetes mellitus	5.36e-06	9.67e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—GSTM1—type 2 diabetes mellitus	5.35e-06	9.65e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—LPL—type 2 diabetes mellitus	5.25e-06	9.48e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—ADCY5—type 2 diabetes mellitus	5.14e-06	9.28e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—GPX1—type 2 diabetes mellitus	5.12e-06	9.25e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—MMP9—type 2 diabetes mellitus	5.1e-06	9.2e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	5.04e-06	9.1e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—CD36—type 2 diabetes mellitus	4.99e-06	9e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	4.94e-06	8.92e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—PPP2CA—type 2 diabetes mellitus	4.92e-06	8.89e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—MTHFR—type 2 diabetes mellitus	4.73e-06	8.53e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—SRC—type 2 diabetes mellitus	4.7e-06	8.48e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—PPARA—type 2 diabetes mellitus	4.64e-06	8.37e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	4.58e-06	8.26e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—AGT—type 2 diabetes mellitus	4.49e-06	8.11e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—CALM1—type 2 diabetes mellitus	4.41e-06	7.97e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—APOE—type 2 diabetes mellitus	4.4e-06	7.94e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—APOA1—type 2 diabetes mellitus	4.35e-06	7.85e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—IL6—type 2 diabetes mellitus	4.24e-06	7.66e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	4.2e-06	7.58e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—IL6—type 2 diabetes mellitus	4.15e-06	7.5e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—EGFR—type 2 diabetes mellitus	4.12e-06	7.44e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—AKT1—type 2 diabetes mellitus	3.91e-06	7.07e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—AKT1—type 2 diabetes mellitus	3.83e-06	6.92e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—PPARG—type 2 diabetes mellitus	3.83e-06	6.92e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—INS—type 2 diabetes mellitus	3.76e-06	6.79e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—ALB—type 2 diabetes mellitus	3.45e-06	6.22e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—NOS3—type 2 diabetes mellitus	3.3e-06	5.95e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	3.3e-06	5.95e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—IL6—type 2 diabetes mellitus	3.16e-06	5.71e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—PTGS2—type 2 diabetes mellitus	3.01e-06	5.44e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.92e-06	5.27e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—AKT1—type 2 diabetes mellitus	1.51e-06	2.74e-05	CbGpPWpGaD
